SQUAWK/NEWS
Menu
Live News EQUITY L impact

Xilio Therapeutics Files S-3/A

Xilio Therapeutics amends SEC filing. No details disclosed.

XLO

Filed: 2026-05-27 AccNo: 0001193125-26-242204 Size: 2 MB